课题基金 / 基金详情

项目摘要

项目成果

THOMAS Arthur PEARSON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Rochester Clinical and Translational Science Award (RCTSA) Program proposes continuation of its dual goals: 1) To organize, support, and expand clinical and translational research at the University of Rochester within an academic home, the University of Rochester Clinical and Translational Science Institute (URCTSI), and 2) To integrate and collaborate with regional and national institutions to expand a National Clinical and Translational Research Network. The RCTSA Program has truly transformed the University of Rochester Medical Center (URMC), with the construction of a state-of-the-art Clinical and Translational Science Building, the integration of clinical and translational science into the shared vision for URMC research, a successful system of dynamic governance, expansion of research resources, and enthusiastic participation and leadership in the National CTSA Consortium. To continue this momentum, the UR-CTSI will carry out a number of specific aims. First, three new key functions will be implemented: Public-Private Partnerships, Tl Translation, and Comparative Effectiveness Research. Existing Key Functions will be reorganized and consolidated to provide better support of investigators by an expanded Office of Regulatory Support, a Navigator/Consultation Service, and an Incubator Program consolidating Pilot Studies, Novel Methodologies, and Translational Technologies Key Functions. The CTSI will establish and foster four centers of research excellence across the spectrum of research translation: Center for Human Experimental Therapeutics (Tl Research); Clinical Research Center (T1-3 Research); Center for Research Implementation and Translation (T2-3 research under School of Nursing sponsorship); and Center for Community Health (T2-3 research). A broad range of education, training, and career development programs will continue to meet research workforce needs. The UR-CTSI will be an active participant in the National CTSA consortium with sharing of expertise, methods, data, and curricula. The Upstate New York Translational Research Network (UNYTRN) will be expanded to support the region's biomedical research institutions. Finally, the UR-CTSI will be evaluated through the measurement of rigorous performance outcomes.
期刊论文(29)
专著(0)
科研奖励(0)
会议论文
Long-term survival among Hodgkin's lymphoma patients with gastrointestinal cancer: a population-based study.
霍奇金淋巴瘤合并胃肠癌患者的长期生存:一项基于人群的研究。
DOI: 10.1093/annonc/mds218
发表时间: 2013
期刊: Annals of oncology : official journal of the European Society for Medical Oncology
影响因子: --
作者: [Youn,P, Li,H, Milano,MT, Stovall,M, Constine,LS, Travis,LB]
通讯作者: Travis,LB
Identification of those at risk for diabetes mellitus can comparative effectiveness research provide the answer?
识别那些有糖尿病风险的人可以通过比较有效性研究提供答案吗?
DOI: 10.1016/j.amepre.2010.10.011
发表时间: 2011
期刊: American journal of preventive medicine
影响因子: 5.5
作者: [Geba,Daniela, Pearson,ThomasA]
通讯作者: Pearson,ThomasA
DOI: 10.1038/jid.2010.13
发表时间: 2010-06
期刊: The Journal of investigative dermatology
影响因子: --
作者: []
通讯作者:
DOI: 10.2106/jbjs.m.00340
发表时间: 2013-12-04
期刊: The Journal of bone and joint surgery. American volume
影响因子: --
作者: [Koehler, Ryan J, Nicandri, Gregg T]
通讯作者: Nicandri, Gregg T
17
    Institutional Career Development Core
    • 批准号:
      9902697
    • 项目类别:
    • 资助金额:
      $68.25万
    • 财政年份:
      2015
    • 负责人:
      THOMAS Arthur PEARSON
    • 依托单位:
    Together: Transforming and Translating Discovery to Improve Health
    • 批准号:
      9126638
    • 项目类别:
    • 资助金额:
      $55.82万
    • 财政年份:
      2015
    • 负责人:
      THOMAS Arthur PEARSON
    • 依托单位:
    Together: Transforming and Translating Discovery to Improve Health
    • 批准号:
      9250827
    • 项目类别:
    • 资助金额:
      $30.58万
    • 财政年份:
      2015
    • 负责人:
      THOMAS Arthur PEARSON
    • 依托单位:
    CTSA INFRASTRUCTURE FOR AIDS RESEARCH
    • 批准号:
      8365028
    • 项目类别:
    • 资助金额:
      $31.15万
    • 财政年份:
      2011
    • 负责人:
      THOMAS Arthur PEARSON
    • 依托单位:
    海外基金